Reigning in costs is a key component of healthcare reform. So it is clear why it will be essential for both providers and policy makers to identify those most at risk for driving up costs.
Reigning in costs is a key component of healthcare reform. So it is clear why it will be essential for both providers and policy makers to identify those most at risk for driving up costs.
According to a recent study published in The American Journal of Managed Care (AJMC), opioid analgesic—treated chronic pain (OAT-CP) patients who showed signs of trouble cost their health plan an estimated $12,877 a year. Precursors of trouble ranged from rapid dose escalation to doctor shopping.
“More than one-third of a sample of OAT-CP patients were identified as potentially problematic opioid users according to the study definitions applied. Healthcare service utilization and expenditures were significantly greater for this group compared with the control group,” reported the study authors.
According to an official press release on the findings:
Of the patients in the study, 39% showed signs of problematic behavior, which included doctor shopping (defined as receiving fills from 5 or more prescribers in a year) and rapid dose escalation (defined as either a 50% increase in opioid dose in the first 3 months or a 100% increase in the follow-up period). Compared with the control group, this group had:
However, proper caution and monitoring can reduce risk of opioid misuse or adverse outcomes.
“[There are] a number of tools and approaches clinicians should use to safely prescribe opioids,” the study said. “These include checking prescription drug monitoring programs, which track information on controlled substance prescriptions filled in a state, taking a careful history of substance abuse and other mental health problems, conducting routine urine drug screens in concert with pain management agreements, and making use of pain medicine consultants when problems arise.”
Read the full study here.
Around the Web
AJMC: Recognizing Certain Indicators Can Prevent Opioid Misuse and Overdose [AJMC]
Study: Pain Patients Who Show Signs of Trouble Cost Health Plan an Extra $12,877 a Year [AJMC]
Health Equity & Access Weekly Roundup: November 2, 2024
November 2nd 2024This week’s Center on Health Equity & Access highlights emphasize the role of social determinants of health in policy-making and underscore the importance of addressing rising costs and challenges employers face.
Read More
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years
June 27th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.
Listen
Overhauling Quality Measurement in the US: Measure What Matters
October 30th 2024As the US charts its course through the next political era, it is crucial that we boldly allocate resources and prioritize what truly impacts patients. When faced with complexity, feasibility concerns, or entrenched norms, we must proclaim: “It’s the outcomes, stupid.”
Read More